iTonic Holdings (ITOC) Current Leases (2023 - 2024)
iTonic Holdings' (ITOC) quarterly Current Leases came in at $54451.0 in Q2 2024, up 7.13% quarter-over-quarter from $50825.0 in Q4 2023.
Powered by 
Analysis
iTonic Holdings (ITOC) Current Leases (2023 - 2024) Analysis & Trends
iTonic Holdings has disclosed Current Leases across 2 years of filings, most recently posting $54451.0 for Q2 2024.
- In Q2 2024, Current Leases changed N/A year-over-year to $54451.0; the TTM figure through Jun 2024 stood at $54451.0 (changed N/A YoY), while the FY2023 annual figure was $50825.0, changed N/A from the prior year.
- Current Leases came in at $54451.0 for Q2 2024 at iTonic Holdings, up from $50825.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $54451.0 in Q2 2024 to a low of $50825.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.10 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 81.00 Mn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 20.70 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 35.60 Mn |
| 10 | iTonic Holdings | 4.83 Mn | 1.90 Mn | - | - |